Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Karos Pharmaceuticals Inc.
DescriptionTryptophan hydroxylase 1 (TPH1; TPH) inhibitor
Molecular Target Tryptophan hydroxylase 1 (TPH1) (TPH)
Mechanism of ActionTryptophan hydroxylase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation U.S. - Orphan Drug (Treat pulmonary arterial hypertension (PAH))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today